SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-057627
Filing Date
2018-11-06
Accepted
2018-11-06 16:17:25
Documents
77
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505338_10q.htm 10-Q 678439
2 EXHIBIT 10.1 tv505338_ex10-1.htm EX-10.1 421766
3 EXHIBIT 31.1 tv505338_ex31-1.htm EX-31.1 12773
4 EXHIBIT 31.2 tv505338_ex31-2.htm EX-31.2 12085
5 EXHIBIT 32.1 tv505338_ex32-1.htm EX-32.1 6017
  Complete submission text file 0001144204-18-057627.txt   8684163

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anip-20180930.xml EX-101.INS 2662647
7 XBRL TAXONOMY EXTENSION SCHEMA anip-20180930.xsd EX-101.SCH 47244
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20180930_cal.xml EX-101.CAL 56148
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20180930_def.xml EX-101.DEF 351508
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20180930_lab.xml EX-101.LAB 361660
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20180930_pre.xml EX-101.PRE 392719
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 181163210
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1